MBX Biosciences (MBX) : 3-month performance

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. 

• Sector: Healthcare
• Industry: Biotechnology
• Full Time Employees: 38
• Founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018
• Headquartered in Carmel, Indiana
• https://mbxbio.com